1
|
Gao Q, Yang H, Masood U, Zhou C, Cen Y, Song Y. Lumbar Disc Herniation with Contralateral Symptoms: A Case-Series of 11 Patients and Literature Review. Orthop Surg 2023; 15:2839-2847. [PMID: 37749774 PMCID: PMC10622262 DOI: 10.1111/os.13849] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/30/2023] [Revised: 07/02/2023] [Accepted: 07/07/2023] [Indexed: 09/27/2023] Open
Abstract
OBJECTIVE Lumbar disc herniation (LDH) is a common pathology that typically causes unilateral radiculopathy on the same side as herniation, while patients may occasionally present with contralateral symptoms. Owing to the rare incidence of LDH with contralateral symptoms, the pathological mechanism remains unclear and the optimal surgical strategy is a subject of debate. This study aimed to provide new insights into the pathological mechanism of contralateral symptoms and assess the efficacy of ipsilateral hemilaminectomy and discectomy surgery in this population. METHODS This study was a retrospective, single-center, clinical case series, including 11 LDH cases with exclusive contralateral symptoms. We searched for LDH cases that were presented at our institution between January 2011 and December 2020. Adult LDH Patients with contralateral radicular pains were included, while those with ipsilateral radiculopathy, lumbar stenosis, foraminal stenosis on the symptomatic side, multilevel disc herniations, scoliosis, and lumbar operation history were excluded. Visual Analog Scale (VAS), clinical features, radiographic images, and other data were collected from the study cohort of 11 cases for further analysis. We also reviewed LDH cases in English literature from 1978 to 2023 to analyze their clinical characteristics and treatment. RESULTS The incidence rate of LDH with contralateral symptoms in single-level LDH cases was 0.32%. The average age of our 11 cases was 49.3 years old, and five of them were female (45.5%). All individuals had single-level lateral LDH, with six cases (54.5%) located at L4-5 and five cases (45.5%) located at L5-S1. Upon admission, patients presented with lower back pain (seven cases, 63.6%), radicular pain (seven cases, 63.6%), hypoesthesia (seven cases, 63.6%), and muscle weakness (one case, 9.1%) on the contralateral side alone. Each case experienced ipsilateral hemilaminectomy and discectomy, and no lateral recess stenosis, hypertrophy of facets or ligaments, and sequestrated discs were found during surgery. All of them have good pain relief with two cases reporting no pain and nine cases reporting only mild pain at the last follow-up. CONCLUSIONS Based on the surgical findings of our 11 LDH cases with contralateral symptoms, we hypothesized that the contralateral symptoms might be produced when the nerve root on the contralateral symptomatic side was tightly pulled by the herniated disc via the dural mater. Ipsilateral hemilaminectomy and discectomy surgery effectively and efficiently relieve the symptoms without postoperative complications for these patients.
Collapse
Affiliation(s)
- Qingyang Gao
- Department of Plastic and Burn Surgery, West China HospitalSichuan UniversityChengduChina
| | - Huiliang Yang
- Department of Orthopedics, Orthopedic Research Institute, West China HospitalSichuan UniversityChengduChina
| | - Umar Masood
- Jacobs School of Medicine and Biomedical SciencesUniversity at Buffalo, The State University of New YorkBuffaloNew YorkUSA
| | - Chunguang Zhou
- Department of Orthopedics, Orthopedic Research Institute, West China HospitalSichuan UniversityChengduChina
| | - Ying Cen
- Department of Plastic and Burn Surgery, West China HospitalSichuan UniversityChengduChina
| | - Yueming Song
- Department of Orthopedics, Orthopedic Research Institute, West China HospitalSichuan UniversityChengduChina
| |
Collapse
|
2
|
Li Q, Hu B, Masood U, Zhang Z, Yang X, Liu L, Feng G, Yang H, Song Y. A Comparison of Corpectomy ACDF Hybrid Procedures with Nano-Hydroxyapatite/Polyamide 66 Cage and Titanium Mesh Cage for Multi-level Degenerative Cervical Myelopathy: A Stepwise Propensity Score Matching Analysis. Orthop Surg 2023; 15:2830-2838. [PMID: 37749767 PMCID: PMC10622274 DOI: 10.1111/os.13883] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/27/2023] [Revised: 07/29/2023] [Accepted: 08/03/2023] [Indexed: 09/27/2023] Open
Abstract
OBJECTIVE Previous studies have found satisfactory clinical results with the nano-hydroxyapatite/polyamide 66 (n-HA/PA66) cage to reconstruct the stability of anterior cervical column. However, studies evaluating the long-term outcomes of the n-HA/PA66 cage in multi-level degenerative cervical myelopathy (MDCM) have not been reported. This study aims to compare the outcomes of corpectomy anterior cervical discectomy and fusion (ACDF) hybrid procedures between the n-HA/PA66 cage and titanium mesh cage (TMC) to treat MDCM. METHODS After the screening for eligibility, this retrospective study involved 90 patients who underwent corpectomy ACDF hybrid (CACDFH) procedure from June 2013 to June 2018. The CACDFH procedure is the combination of ACDF and anterior cervical corpectomy and fusion (ACCF). According to the cage utilized, we categorized patients into a n-HA/PA66 cage group and a TMC group. Then, stepwise propensity score matching (PSM) was performed to maintain comparable clinical data between groups. All the patients were followed up ≥4 years and the longest follow-up time was 65.43 (±11.49) months. Cage subsidence, adjacent segment degeneration (ASD), segmental height (SH), segmental angle (SA), cervical lordosis (CL), and clinical data (visual analogue scale [VAS] and Japanese Orthopaedic Association [JOA] score) was evaluated preoperatively, at 1 week, and at the final surgery follow-up. The independent student's t test and chi-square test were applied to compare the differences between groups. RESULTS Through PSM analysis, 25 patients from the n-HA/PA66 group were matched to 25 patients in the TMC group. The occurrence of ASD was 16.0% (4/25) in the n-HA/PA 66 group, which was significantly less than in the TMC group at 44.0% (11/25) (p = 0.031). Moreover, the cage subsidence rate was significantly higher in the TMC group as compared to the n-HA/PA 66 group (40.0% vs. 12.0%, p = 0.024). But there was no significant difference in SH, SA, and CL at any time after surgery as determined through follow-up. The VAS and JOA scores significantly improved in both groups at 3 months postoperative and at final follow-up. However, there were no significant differences in the VAS and JOA score at any time between the two groups in preoperative (p > 0.05). CONCLUSION The n-HA/PA66 cage is associated with lower rate of cage subsidence and ASD than the TMC in the treatment of MDCM. The n-HA/PA66 cage could be superior to the TMC in corpectomy ACDF hybrid procedures.
Collapse
Affiliation(s)
- Qiujiang Li
- Department of OrthopaedicsOrthopaedic Research Institute, West China Hospital, Sichuan UniversityChengduChina
| | - Bowen Hu
- Department of OrthopaedicsOrthopaedic Research Institute, West China Hospital, Sichuan UniversityChengduChina
| | - Umar Masood
- Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, The State University of New YorkBuffaloNYUSA
| | - Zhuang Zhang
- Department of OrthopaedicsOrthopaedic Research Institute, West China Hospital, Sichuan UniversityChengduChina
| | - Xi Yang
- Department of OrthopaedicsOrthopaedic Research Institute, West China Hospital, Sichuan UniversityChengduChina
| | - Limin Liu
- Department of OrthopaedicsOrthopaedic Research Institute, West China Hospital, Sichuan UniversityChengduChina
| | - Ganjun Feng
- Department of OrthopaedicsOrthopaedic Research Institute, West China Hospital, Sichuan UniversityChengduChina
| | - Huiliang Yang
- Department of OrthopaedicsOrthopaedic Research Institute, West China Hospital, Sichuan UniversityChengduChina
| | - Yueming Song
- Department of OrthopaedicsOrthopaedic Research Institute, West China Hospital, Sichuan UniversityChengduChina
| |
Collapse
|
3
|
Chen K, Wang L, Gao Q, Masood U, Zeng Z, Yang H, Song Y. Tranexamic acid can reduce blood loss in adolescent scoliosis surgery: a systematic review and meta-analysis. BMC Musculoskelet Disord 2023; 24:686. [PMID: 37644447 PMCID: PMC10463947 DOI: 10.1186/s12891-023-06811-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/21/2022] [Accepted: 08/18/2023] [Indexed: 08/31/2023] Open
Abstract
BACKGROUND Tranexamic acid (TXA) has been widely used in orthopedic surgery, but its efficacy in adolescent scoliosis (AS) surgery remains unclear in the literature. The purpose of this systematic review and meta-analysis is to evaluate the safety and efficacy of TXA compared to placebo treatment during or after AS surgery, by gathering data from randomized both controlled trials (RCTs) and non-RCTs. METHODS English and Chinese electronic databases including PubMed, Web of Science, Embase, Cochrane, CNKI, and Wan Fang database were searched to identify the relevant literature up until August 2022. The primary outcomes were intraoperative blood loss and total blood loss. The secondary outcomes included the need for transfusion, postoperative hemoglobin (Hb) level, and change in Hb level. Stata 17 was used for data analysis and the risk of bias was assessed. We followed the PRISMA checklist to ensure the quality of this article. RESULTS Twelve studies (795 participants) were included in the meta-analysis for intraoperative blood loss during surgery. The results suggest that TXA can reduce the intraoperative blood loss of the patients (MD = -306.40ml, 95%CI = -404.04ml to -208.77ml, p < 0.001). Six studies (2027 patients) were included in the meta-analysis for total blood loss. The pooled result shows that the total blood loss of the TXA group was significantly lower than that of the control group (MD = -779.24ml, 95% CI = -1157.10ml to -410.39ml, p < 0.001). Five studies (419 patients) were included in the meta-analysis for postoperative Hb level and shows a non-significant outcome (MD = 5.09 g/l, 95%CI = 2.92 g/l to 7.25 g/l, p = 0.611). Three studies (268 patients) were included in the meta-analysis for the postoperative Hb level. There is a non-significant decrease in the TXA group (MD = -0.23 g/l, 95%CI = -0.48 g/l to 0.01 g/l, p = 0.319). Eight studies (670 patients) reported data on the need for transfusion after surgery. The overall relative risks (RR) showed a significant difference between the TXA and control group, with a lower risk of transfusion in the TXA group (RR = 0.547, 95%CI = 0.308 to 0.972, p = 0.04). CONCLUSIONS The meta-analysis of the data reveals that TXA usage is associated with a significant reduction in intraoperative and total blood loss, a lower risk of transfusion, and a non-significant change in postoperative Hb levels in AS surgery However, it should be noted that the surgical operation situations varied across different studies. Therefore, further research is required to investigate the effects of TXA on specific subgroups of gender, operation time, and blood transfusion indicators. Overall, our study provides valuable evidence for the clinical management of AS surgery and may inform the development of practice guidelines and protocols for the use of TXA in this setting.
Collapse
Affiliation(s)
- Keyu Chen
- Department of Orthopedic Surgery and Orthopedic Research Institute, West China Hospital, Sichuan University, Chengdu, 610041, China
| | - Liang Wang
- Department of Orthopedic Surgery and Orthopedic Research Institute, West China Hospital, Sichuan University, Chengdu, 610041, China
| | - Qingyang Gao
- Department of Orthopedic Surgery and Orthopedic Research Institute, West China Hospital, Sichuan University, Chengdu, 610041, China
| | - Umar Masood
- Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, The State University of New York, Buffalo, NY, USA
| | - Zhimou Zeng
- Department of Orthopedic Surgery and Orthopedic Research Institute, West China Hospital, Sichuan University, Chengdu, 610041, China
| | - Huiliang Yang
- Department of Orthopedic Surgery and Orthopedic Research Institute, West China Hospital, Sichuan University, Chengdu, 610041, China.
| | - Yueming Song
- Department of Orthopedic Surgery and Orthopedic Research Institute, West China Hospital, Sichuan University, Chengdu, 610041, China
| |
Collapse
|
4
|
Karsch L, Beyreuther E, Enghardt W, Gotz M, Masood U, Schramm U, Zeil K, Pawelke J. Towards ion beam therapy based on laser plasma accelerators. Acta Oncol 2017; 56:1359-1366. [PMID: 28828925 DOI: 10.1080/0284186x.2017.1355111] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
Only few ten radiotherapy facilities worldwide provide ion beams, in spite of their physical advantage of better achievable tumor conformity of the dose compared to conventional photon beams. Since, mainly the large size and high costs hinder their wider spread, great efforts are ongoing to develop more compact ion therapy facilities. One promising approach for smaller facilities is the acceleration of ions on micrometre scale by high intensity lasers. Laser accelerators deliver pulsed beams with a low pulse repetition rate, but a high number of ions per pulse, broad energy spectra and high divergences. A clinical use of a laser based ion beam facility requires not only a laser accelerator providing beams of therapeutic quality, but also new approaches for beam transport, dosimetric control and tumor conformal dose delivery procedure together with the knowledge of the radiobiological effectiveness of laser-driven beams. Over the last decade research was mainly focused on protons and progress was achieved in all important challenges. Although currently the maximum proton energy is not yet high enough for patient irradiation, suggestions and solutions have been reported for compact beam transport and dose delivery procedures, respectively, as well as for precise dosimetric control. Radiobiological in vitro and in vivo studies show no indications of an altered biological effectiveness of laser-driven beams. Laser based facilities will hardly improve the availability of ion beams for patient treatment in the next decade. Nevertheless, there are possibilities for a need of laser based therapy facilities in future.
Collapse
Affiliation(s)
- Leonhard Karsch
- Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany
- OncoRay – National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
| | | | - Wolfgang Enghardt
- Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany
- OncoRay – National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
- German Cancer Consortium (DKTK), Dresden, Germany
| | - Malte Gotz
- Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany
- OncoRay – National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
| | - Umar Masood
- Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany
- OncoRay – National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
| | - Ulrich Schramm
- Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany
- Technische Universität Dresden, Dresden, Germany
| | - Karl Zeil
- Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany
| | - Jörg Pawelke
- Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany
- OncoRay – National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
| |
Collapse
|
5
|
Masood U, Cowan TE, Enghardt W, Hofmann KM, Karsch L, Kroll F, Schramm U, Wilkens JJ, Pawelke J. A light-weight compact proton gantry design with a novel dose delivery system for broad-energetic laser-accelerated beams. Phys Med Biol 2017; 62:5531-5555. [DOI: 10.1088/1361-6560/aa7124] [Citation(s) in RCA: 29] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/24/2023]
|
6
|
Masood U, Pavelock N, Sharma A, Lebel RR, Gupta A, Murthy U. A novel PTEN mutation associated with colonic ganglioneuromatous polyps. QJM 2017; 110:385-386. [PMID: 28340209 DOI: 10.1093/qjmed/hcx066] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/08/2017] [Indexed: 11/13/2022] Open
Affiliation(s)
- U Masood
- From the Department of Internal Medicine, SUNY Upstate Medical University
| | - N Pavelock
- Department of Gastroenterology, SUNY Upstate Medical University
| | - A Sharma
- From the Department of Internal Medicine, SUNY Upstate Medical University
| | - R R Lebel
- Division of Development, Behavior and Genetics, SUNY Upstate Medical University
| | - A Gupta
- Department of Gastroenterology, Syracuse Veteran Affairs Hospital, Syracuse, NY, USA
| | - U Murthy
- Department of Gastroenterology, Syracuse Veteran Affairs Hospital, Syracuse, NY, USA
| |
Collapse
|
7
|
Schürer M, Herrmannsdörfer T, Karsch L, Kroll F, Masood U, Sobiella M, Pawelke J. Poster session 33: Radiation therapy IV. BIOMED ENG-BIOMED TE 2017. [DOI: 10.1515/bmt-2017-5078] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
8
|
Karsch L, Beyreuther E, Enghardt W, Gotz M, Hermannsdörfer T, Krause M, Masood U, Pawelke J, Sauerbrey R, Schramm U, Schürer M, Baumann M. Development of laser-driven proton beam therapy. Ann Oncol 2016. [DOI: 10.1093/annonc/mdw392.49] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
9
|
Masood U, Baumann M, Cowan T, Enghardt W, Herrmannsdörfer T, Karsch L, Kroll F, Schramm U, Schürer M, Pawelke J. Status of the Development of a Novel Compact Proton Therapy Gantry System Based on Pulsed Magnets for Laser-Driven Beams. Int J Radiat Oncol Biol Phys 2016. [DOI: 10.1016/j.ijrobp.2016.06.2162] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
10
|
Hofmann KM, Masood U, Pawelke J, Wilkens JJ. A treatment planning study to assess the feasibility of laser-driven proton therapy using a compact gantry design. Med Phys 2015; 42:5120-9. [DOI: 10.1118/1.4927717] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
11
|
Masood U, Baumann M, Bussmann M, Cowan T, Enghardt W, Herrmannsdoerfer T, Hofmann K, Kaluza M, Karsch L, Kroll F, Schramm U, Schuerer M, Wilkens J, Pawelke J. Development of a Novel Compact Particle Therapy Facility With Laser Driven Ion Beams via Gantry Systems Based on Pulsed Magnets. Int J Radiat Oncol Biol Phys 2014. [DOI: 10.1016/j.ijrobp.2014.05.2596] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
12
|
Masood U, Bussmann M, Cowan T, Enghardt W, Kaluza M, Herrmannsdoerfer T, Krause M, Pawelke J, Sauerbrey R, Schramm U, Baumann M. Development of Laser-Driven Proton Beam Therapy. Ann Oncol 2014. [DOI: 10.1093/annonc/mdu358.3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
13
|
Hofmann K, Masood U, Pawelke J, Wilkens J. SU-D-BRE-05: Feasibility and Limitations of Laser-Driven Proton Therapy: A Treatment Planning Study. Med Phys 2014. [DOI: 10.1118/1.4887876] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
14
|
Mehmood T, Masood A, Saeed K, Munnawar A, Masood U, Ali M, Irfan N. EP-1084: Biochemical progression rate with diethylstilbesterol in hormone refractory prostate cancer patients. Radiother Oncol 2013. [DOI: 10.1016/s0167-8140(15)33390-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
15
|
Masood A, Muhammad A, Mehmood T, Masood U, Hameed S, Ahmed I. EP-1095 NADIR PSA AS PREDICTIVE MARKER FOR BIOCHEMICAL RELAPSE IN INTERMEDIATE AND HIGH RISK LOCALIZED PROSTATE CANCER. Radiother Oncol 2012. [DOI: 10.1016/s0167-8140(12)71428-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
16
|
Bukhari M, Masood U, Mehmood T, Masood A, Haider I, Khan A, Majeed H, Siddiqui N. EP-0993 BREAST CANCER SUBTYPES BASED ON ER/PR AND HER2 EXPRESSION IN PAKISTANI WOMEN. Radiother Oncol 2012. [DOI: 10.1016/s0167-8140(12)71326-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
17
|
Mehmood T, Bukhari M, Masood U, Haider I, Khan A, Majeed H, Shah M, Siddiqui N. EP-1006 TRIPLE NEGATIVE VERSUS NON TRIPLE NEGATIVE BREAST CANCER IN PAKISTANI WOMEN. Radiother Oncol 2012. [DOI: 10.1016/s0167-8140(12)71339-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
18
|
Haider I, Majeed U, Ali M, Ali W, Rafay A, Manzoor U, Masood U. EP-1143 TUMOR VOLUME AND CORPUS UTERINE INVASION AS PREDICTORS OF SURVIVAL IN CERVICAL CARCINOMA. Radiother Oncol 2012. [DOI: 10.1016/s0167-8140(12)71476-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
19
|
Masood U, Bukhari M, Masood A, Haider I, Shah M, Rasheed A, Mehmood T, Ali M, Nabia I. EP-1011 OUTCOME OF TRIPLE NEGATIVE (TN) BREAST CARCINOMA AFTER BREAST CONSERVATION WITH RADIOTHERAPY. Radiother Oncol 2012. [DOI: 10.1016/s0167-8140(12)71344-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
20
|
|